GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease—a KDIGO commentary

de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Khunti, K., Liew, A., … Rossing, P. (2025, May 1). GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease—a KDIGO commentary. Kidney International. Elsevier B.V. https://doi.org/10.1016/j.kint.2024.12.019